CIK 0001339970
- Non-accelerated filer
- Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203435077
- Phone
- +1 858-731-8389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Open-market sale Chief Financial Officer sold 390 shares at $7.66 ($2,987)
- 4 Open-market sale President and CEO sold 778 shares at $7.66 ($5,959)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 7,360 shares at an average $4.01 ($29,513)
- 4 Open-market sale Director sold 7,640 shares at an average $4.15 ($31,701)
- 4 Open-market buy Chief Financial Officer bought 1,850 shares at $4.22 ($7,807)
- 4 Open-market buy President and CEO bought 6,000 shares at $4.27 ($25,620)
- 4 Open-market sale General Counsel sold 322 shares at $3.62 ($1,166)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 8,447 shares at $3.64 ($30,739)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 17 · 329 filings